← FDA Drug Approvals (Drugs@FDA)

ERYTHROMYCIN ESTOLATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: WATSON LABS · Approved 1979-06-14

Drug application

FDA Application #

ANDA062087

Application type

Abbreviated New Drug Application (Generic)

Brand name

ERYTHROMYCIN ESTOLATE

Generic name

Erythromycin Estolate

Active ingredients

ERYTHROMYCIN ESTOLATE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Discontinued

Sponsor

WATSON LABS

First approval

1979-06-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown